Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428

About this update from Fujian Haixi Pharmaceuticals Co., Ltd. Class H

Fujian Haixi Pharmaceuticals Co Ltd HKEX:2637:U.S. FDA APPROVES IND APPLICATION OF HX9428 FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

View stock analysis, news, and events for Fujian Haixi Pharmaceuticals Co., Ltd. Class H